Le Lézard
Classified in: Health, Business
Subject: FNC

Independence Blue Cross awards 2023 Clinical Care Innovation Grants to Temple Health and Penn Medicine


PHILADELPHIA, Oct. 31, 2023 /PRNewswire/ -- Independence Blue Cross (Independence) awarded two Clinical Care Innovation Grants (CCI Grants) to Temple Health and Penn Medicine to support projects aimed at improving the quality and delivery of health care. The two projects awarded CCI Grants include:

These grants are part of a larger Clinical Care Innovation Program at Independence. "Through this program, we support providers who are leading the way with powerful approaches to care," said Rodrigo Cerdá, MD, MPH, senior vice president of Health Services and chief medical officer at Independence. "These are approaches that are intended to improve health outcomes, break down barriers to care, and drive increased cost efficiency in the system." To date, Independence has awarded 18 Clinical Care Innovation Grants valued at more than $3 million to five health systems and large specialty groups.

About Independence Blue Cross:
Independence Blue Cross is the leading health insurance organization in southeastern Pennsylvania. For 85 years, we have been enhancing the health and well-being of the people and communities we serve. We deliver innovative and competitively priced health care products and services; pioneer new ways to reward doctors, hospitals, and other health care professionals for coordinated, quality care; and support programs and events that promote wellness. To learn more, visit ibx.com. Connect with us on Facebook, X (formerly Twitter), LinkedIn, and Instagram. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.

CONTACT:







Diana Quattrone
215-815-7828 (cell)
[email protected]

 

SOURCE Independence Blue Cross


These press releases may also interest you

at 22:30
Today, a decision was issued by the Court of Appeals Division I in the State of Washington in Erickson v. Monsanto, ruling in Monsanto's favor on multiple grounds. This decision reverses the initial verdict of $185 million in its entirety and...

at 21:30
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Poseida Therapeutics, Inc.  today announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos") and Poseida have entered into a...

at 21:00
Memorial Regional Hospital in Florida has earned the prestigious title of being the state's inaugural Resuscitation Center of Excellence (RCOE), underscoring the hospital's adherence to over 30 evidence-based criteria in providing top-tier cardiac...

at 19:31
Momcozy, a trusted global brand specializing in solution-focused maternal and baby care products since 2018, has announced their collaboration with 1 Natural Way (1NW), a nationally recognized Durable Medical Equipment company catering to the precise...

at 19:01
Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today announced the completion of a...

at 17:49
The ALS Association today celebrated the beginning of ALS Awareness Month and the 10th Anniversary of the Ice Bucket Challenge, which inspired the world to join the fight against ALS in the summer of 2014. Throughout May and the summer, the ALS...



News published on and distributed by: